Industry Sponsored
BME
2025-2026
Fall
Winter
Spring

DermaSpect

DermaSpect

Summary

Making the Invisible Visible

DermaVision is developing DermaSpect, a portable multispectral imaging device that uses UV-A, visible, and near-infrared (NIR) wavelengths to capture subsurface bruise information that may not be visible under standard lighting conditions. Our goal: improve consistency, objectivity, and equity in clinical and forensic imaging.

The Problem

Why This Matters

Bruise documentation plays an important role in both healthcare and forensic investigations, especially in cases involving domestic violence, sexual assault, child abuse, and physical trauma. However, current bruise assessment methods still rely heavily on visual inspection and standard photography, which are subjective and inconsistent.

According to national statistics, over 10 million domestic violence cases occur annually in the United States, and approximately 44.2% of victims are people of color. Existing bruise detection and aging methods are often less accurate on highly pigmented skin because melanin absorbs much of the visible light spectrum and can mask underlying chromophores such as hemoglobin.

As a result, bruises are often less visible or entirely missed, and documented inconsistently. This can negatively impact medical treatment, injury tracking, forensic documentation, and legal evidence collection.

Technical Approach/Methodology

Our Solution

Introducing DermaSpect

DermaSpect is a portable multispectral bruise quantification device designed to improve bruise visibility and documentation across diverse skin tones. Instead of relying only on visible light, the system uses multiple wavelengths of illumination, including UV-A and near-infrared (NIR), to capture subsurface information associated with bruise healing.

The system integrates specialized LEDs, a camera sensor, custom PCB electronics, and a handheld housing into a compact imaging device. By combining these components into a single platform, DermaSpect aims to provide more objective imaging compared to standard photography.

How It Works

Bruises undergo biochemical changes during healing. Chromophores such as hemoglobin and bilirubin absorb and reflect light differently over time. By imaging across multiple wavelengths, DermaSpect aims to capture spectral information associated with these changes.

  1. Illumination: UV-A, visible, or NIR LEDs illuminate the target skin region
  2. Image Capture: Camera captures spectral response from the illuminated tissue
  3. Spectral Separation: Wavelength bands are isolated for analysis
  4. Feature Analysis: Spectral and spatial differences are analyzed
  5. Bruise Visualization: Subsurface bruise information becomes more visible
  6. Future Goal: Support bruise aging and injury assessment

 

Algorithm & Image Processing

The DermaVision algorithm pipeline is designed to analyze multispectral image data and identify spectral patterns associated with bruising. After image capture, preprocessing steps such as illumination correction and normalization are used to improve consistency between images. The system then extracts spectral and spatial features related to bruise appearance and chromophore changes during healing.

The long-term goal is to compare these spectral signatures against a bruise imaging database to support more objective bruise characterization and future time approximation. Future development may also incorporate machine learning approaches to improve classification accuracy across different skin tones and imaging conditions.

Outcomes

Go-to-Market Approach

  • Pilot partnerships with SANE (Sexual Assault Nurse Examiner) programs and university hospital forensic nursing departments to validate clinical utility
  • Conference presence at forensic nursing (IAFN) and clinical forensic medicine conferences to build professional credibility
  • Grant and research funding through NIH and DOJ programs focused on domestic violence documentation and health equity
  • Direct sales to hospital systems and law enforcement agencies once regulatory pathway is established